Obicetrapib and renal function: A welcome signal, but not yet a kidney story
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Chronic kidney disease (CKD) and atherosclerotic cardiovascular disease (ASCVD) frequently coexist and mutually amplify risk [1]. CKD development and progression share traditional ASCVD risk factors such as ageing, hypertension, diabetes, and obesity, but also include immune-mediated and inflammatory diseases among others [1]. There are differences with inflammation promoting structural and functional alterations within the renal microvasculature, glomeruli, and tubulointerstitium, ultimately leading to progressive nephron loss [1]. Beyond these mechanisms, disturbances in lipoprotein metabolism may also contribute to cardiovascular and renal injury.
Fields of Study & Subjects
Chronic Kidney Disease and Diabetes
Lipoproteins and Cardiovascular Health
Blood Pressure and Hypertension Studies
Publication details
- Journal / source
- American Journal of Preventive Cardiology
- Volume
- 27
- Pages
- 101546–101546
- Publication date
- 27 March 2026
- Language
- EN